Facciorusso A - Search Results

1

Microwave ablation determines similar survival outcomes as compared to radiofrequency ablation for the treatment of hepatocellular carcinoma.

Khan A, Mostowy M, Owusu M, Mutambanengwe M, Habimana S, Bence S, Facciorusso A. Khan A, et al. Among authors: facciorusso a. Expert Rev Gastroenterol Hepatol. 2021 Jul;15(7):829-833. doi: 10.1080/17474124.2021.1869939. Epub 2020 Dec 30. Expert Rev Gastroenterol Hepatol. 2021. PMID: 33356655

2

Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation.

Facciorusso A, Del Prete V, Antonino M, Neve V, Crucinio N, Di Leo A, Carr BI, Barone M. Facciorusso A, et al. J Gastroenterol Hepatol. 2014 Nov;29(11):1905-10. doi: 10.1111/jgh.12618. J Gastroenterol Hepatol. 2014. PMID: 24731153

3

Post-recurrence survival in hepatocellular carcinoma after percutaneous radiofrequency ablation.

Facciorusso A, Del Prete V, Antonino M, Crucinio N, Neve V, Di Leo A, Carr BI, Barone M. Facciorusso A, et al. Dig Liver Dis. 2014 Nov;46(11):1014-9. doi: 10.1016/j.dld.2014.07.012. Epub 2014 Jul 29. Dig Liver Dis. 2014. PMID: 25085684

4

MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma.

Facciorusso A, Licinio R, Carr BI, Di Leo A, Barone M. Facciorusso A, et al. Expert Rev Gastroenterol Hepatol. 2015 Jul;9(7):993-1003. doi: 10.1586/17474124.2015.1040763. Epub 2015 Apr 27. Expert Rev Gastroenterol Hepatol. 2015. PMID: 25915713 Review.

5

Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: a glimmer of light after the storm trial?

Facciorusso A, Muscatiello N, Di Leo A, Barone M. Facciorusso A, et al. Am J Gastroenterol. 2015 May;110(5):770-1. doi: 10.1038/ajg.2015.80. Am J Gastroenterol. 2015. PMID: 25942304 No abstract available.

6

Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients.

Facciorusso A, Del Prete V, Crucinio N, Muscatiello N, Carr BI, Di Leo A, Barone M. Facciorusso A, et al. J Gastroenterol Hepatol. 2015 Nov;30(11):1643-50. doi: 10.1111/jgh.12988. J Gastroenterol Hepatol. 2015. PMID: 25974743

7

Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma.

Facciorusso A, Mariani L, Sposito C, Spreafico C, Bongini M, Morosi C, Cascella T, Marchianò A, Camerini T, Bhoori S, Brunero F, Barone M, Mazzaferro V. Facciorusso A, et al. J Gastroenterol Hepatol. 2016 Mar;31(3):645-53. doi: 10.1111/jgh.13147. J Gastroenterol Hepatol. 2016. PMID: 26331807

8

Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis.

Facciorusso A, Di Maso M, Muscatiello N. Facciorusso A, et al. Int J Hyperthermia. 2016 May;32(3):339-44. doi: 10.3109/02656736.2015.1127434. Epub 2016 Jan 21. Int J Hyperthermia. 2016. PMID: 26794414 Free article. Review.

9

Prognostic role of 25-hydroxyvitamin D in patients with liver metastases from colorectal cancer treated with radiofrequency ablation.

Facciorusso A, Del Prete V, Muscatiello N, Crucinio N, Barone M. Facciorusso A, et al. J Gastroenterol Hepatol. 2016 Aug;31(8):1483-8. doi: 10.1111/jgh.13326. J Gastroenterol Hepatol. 2016. PMID: 26896637

10

Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis.

Facciorusso A, Di Maso M, Muscatiello N. Facciorusso A, et al. Dig Liver Dis. 2016 Jun;48(6):571-7. doi: 10.1016/j.dld.2016.02.005. Epub 2016 Feb 21. Dig Liver Dis. 2016. PMID: 26965785 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

425 results

Search Page

Filters